Zobrazeno 1 - 10 of 324 pro vyhledávání: '"GYERGYAY F"'
1
Akademický článek
Prediction of PSA Response after Dexamethasone Switch during Abiraterone Acetate + Prednisolone Treatment of Metastatic Castration-Resistant Prostate Cancer Patients.
Autor: Fekete B; Department of Endocrinology and Diabetology, Internal Medicine II, Central Hospital of Northern Pest-Military Hospital, Podmaniczky u. 109-111, 1062 Budapest, Hungary., Biró K; Department of Genitourinary Medical Oncology and Clinical Pharmacology, National Institute of Oncology, Comprehensive Cancer Center, Ráth Gy. u. 7-9, 1122 Budapest, Hungary., Gyergyay F; Department of Genitourinary Medical Oncology and Clinical Pharmacology, National Institute of Oncology, Comprehensive Cancer Center, Ráth Gy. u. 7-9, 1122 Budapest, Hungary., Polk N; Department of Visceral Surgery, National Institute of Oncology, Comprehensive Cancer Center, Ráth Gy. u. 7-9, 1122 Budapest, Hungary., Horváth O; Department of Genitourinary Medical Oncology and Clinical Pharmacology, National Institute of Oncology, Comprehensive Cancer Center, Ráth Gy. u. 7-9, 1122 Budapest, Hungary., Géczi L; Department of Genitourinary Medical Oncology and Clinical Pharmacology, National Institute of Oncology, Comprehensive Cancer Center, Ráth Gy. u. 7-9, 1122 Budapest, Hungary.; National Tumor Biology Laboratory, National Institute of Oncology, Comprehensive Cancer Center, Ráth Gy. u. 7-9, 1122 Budapest, Hungary., Patócs A; National Tumor Biology Laboratory, National Institute of Oncology, Comprehensive Cancer Center, Ráth Gy. u. 7-9, 1122 Budapest, Hungary.; Department of Laboratory Medicine, Semmelweis University, Üllői út 78/b, 1083 Budapest, Hungary.; Department of Molecular Genetics, National Institute of Oncology, Comprehensive Cancer Center, Ráth Gy 7-9, 1122 Budapest, Hungary., Budai B; Department of Molecular Genetics, National Institute of Oncology, Comprehensive Cancer Center, Ráth Gy 7-9, 1122 Budapest, Hungary.
Publikováno v: Cancers [Cancers (Basel)] 2024 Aug 03; Vol. 16 (15). Date of Electronic Publication: 2024 Aug 03.
Zobrazit plný text záznamu
2
Akademický článek
A new method to quantify the effect of co-medication on the efficacy of abiraterone in metastatic castration-resistant prostate cancer patients.
Autor: Fekete B; Central Hospital of Northern Pest, Budapest, Hungary., Bársony L; Department of Laboratory Medicine, Semmelweis University, Budapest, Hungary., Biró K; Department of Genitourinary Medical Oncology and Clinical Pharmacology, Comprehensive Cancer Center, National Institute of Oncology, Budapest, Hungary., Gyergyay F; Department of Genitourinary Medical Oncology and Clinical Pharmacology, Comprehensive Cancer Center, National Institute of Oncology, Budapest, Hungary., Géczi L; Department of Genitourinary Medical Oncology and Clinical Pharmacology, Comprehensive Cancer Center, National Institute of Oncology, Budapest, Hungary., Patócs A; Department of Laboratory Medicine, Semmelweis University, Budapest, Hungary.; Department of Molecular Genetics, Comprehensive Cancer Center, National Institute of Oncology, Budapest, Hungary.; National Tumor Biology Laboratory, Comprehensive Cancer Center, National Institute of Oncology, Budapest, Hungary., Budai B; Department of Molecular Genetics, Comprehensive Cancer Center, National Institute of Oncology, Budapest, Hungary.
Publikováno v: Frontiers in pharmacology [Front Pharmacol] 2023 Sep 28; Vol. 14, pp. 1220457. Date of Electronic Publication: 2023 Sep 28 (Print Publication: 2023).
Zobrazit plný text záznamu
3
Akademický článek
[Fertility preservation in testicular cancer patients].
Autor: Martin T; Országos Onkológiai Intézet, Budapest, Hungary. dr.martin.tamas@gmail.com., Dank M; Onkológiai Központ, Semmelweis Egyetem, Budapest, Hungary., Biró K; Országos Onkológiai Intézet, Budapest, Hungary. dr.martin.tamas@gmail.com., Küronya Z; Országos Onkológiai Intézet, Budapest, Hungary. dr.martin.tamas@gmail.com., Gyergyay F; Országos Onkológiai Intézet, Budapest, Hungary. dr.martin.tamas@gmail.com., Nagyiványi K; Országos Onkológiai Intézet, Budapest, Hungary. dr.martin.tamas@gmail.com., Budai B; Országos Onkológiai Intézet, Budapest, Hungary. dr.martin.tamas@gmail.com., Fűrész K; KRIO Intézet, Budapest, Hungary., Géczi L; Országos Onkológiai Intézet, Budapest, Hungary. dr.martin.tamas@gmail.com.
Publikováno v: Magyar onkologia [Magy Onkol] 2021 Mar 17; Vol. 65 (1), pp. 53-57. Date of Electronic Publication: 2019 Aug 14.
Zobrazit plný text záznamu
4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
5
Akademický článek
Predictive Markers of First Line Pazopanib Treatment in Kidney Cancer.
Autor: Küronya Z; Department of Genitourinary Medical Oncology and Clinical Pharmacology, National Institute of Oncology, Ráth György utca 7-9, Budapest, 1122, Hungary. kuronyaz@gmail.com., Szőnyi MD; Semmelweis University, Budapest, Hungary., Nagyiványi K; Department of Genitourinary Medical Oncology and Clinical Pharmacology, National Institute of Oncology, Ráth György utca 7-9, Budapest, 1122, Hungary., Gyergyay F; Department of Genitourinary Medical Oncology and Clinical Pharmacology, National Institute of Oncology, Ráth György utca 7-9, Budapest, 1122, Hungary., Géczi L; Department of Genitourinary Medical Oncology and Clinical Pharmacology, National Institute of Oncology, Ráth György utca 7-9, Budapest, 1122, Hungary., Budai B; Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary., Martin T; Department of Genitourinary Medical Oncology and Clinical Pharmacology, National Institute of Oncology, Ráth György utca 7-9, Budapest, 1122, Hungary., Ladányi A; Department of Surgical and Molecular Pathology, National Institute of Oncology, Budapest, Hungary., Kiss E; Medical Centre, Hungarian Defence Forces, Department of Oncology, Budapest, Hungary., Biró K; Department of Genitourinary Medical Oncology and Clinical Pharmacology, National Institute of Oncology, Ráth György utca 7-9, Budapest, 1122, Hungary.
Publikováno v: Pathology oncology research : POR [Pathol Oncol Res] 2020 Oct; Vol. 26 (4), pp. 2475-2481. Date of Electronic Publication: 2020 Jun 22.
Zobrazit plný text záznamu
6
Akademický článek
Sunitinib Rechallenge After Other Targeted Therapies in Metastatic Renal Cell Carcinoma Patients: A Single-Center, Retrospective Study.
Autor: Nagyiványi K; National Institute of Oncology, Rath Gy. u. 7-9, 1122, Budapest, Hungary., Budai B; National Institute of Oncology, Rath Gy. u. 7-9, 1122, Budapest, Hungary. budai@oncol.hu., Gyergyay F; National Institute of Oncology, Rath Gy. u. 7-9, 1122, Budapest, Hungary., Küronya Z; National Institute of Oncology, Rath Gy. u. 7-9, 1122, Budapest, Hungary., Bíró K; National Institute of Oncology, Rath Gy. u. 7-9, 1122, Budapest, Hungary., Géczi L; National Institute of Oncology, Rath Gy. u. 7-9, 1122, Budapest, Hungary.
Publikováno v: Clinical drug investigation [Clin Drug Investig] 2019 Jun; Vol. 39 (6), pp. 577-583.
Zobrazit plný text záznamu
7
Akademický článek
ERG expression can predict the outcome of docetaxel combinedwith androgen deprivation therapy in metastatic hormone-sensitiveprostate cancer.
Autor: Küronya Z; National Institute of Oncology, Department of Medical Oncology and Clinical Pharmacology 'C', Budapest, Hungary., Sükösd F; Department of Pathology, University of Szeged, Szeged, Hungary., Varga L; Department of Oncotherapy, University of Szeged, Szeged, Hungary., Bíró K; National Institute of Oncology, Department of Medical Oncology and Clinical Pharmacology 'C', Budapest, Hungary., Gyergyay F; National Institute of Oncology, Department of Medical Oncology and Clinical Pharmacology 'C', Budapest, Hungary., Géczi L; National Institute of Oncology, Department of Medical Oncology and Clinical Pharmacology 'C', Budapest, Hungary., Nagyiványi K; National Institute of Oncology, Department of Medical Oncology and Clinical Pharmacology 'C', Budapest, Hungary., Jorgo K; National Institute of Oncology, Department of Radiotherapy, Budapest, Hungary; Semmelweis University, Department of Oncology, Budapest., Szarvas T; Department of Urology, Semmelweis University, Budapest, Hungary., Kovács Á; Boehringer Ingelheim RCV GmbH & Co. KG Branch Office Hungary, Budapest, Hungary., Laczó I; Pándy Kálmán Hospital Gyula, Gyula, Hungary., Varga Z; University of Szeged, Department of Oncotherapy, Szeged, Hungary., Pósfai B; University of Szeged, Department of Oncotherapy, Szeged, Hungary., Pepó J; University of Szeged, Department of Oncotherapy, Szeged, Hungary., Maráz A; University of Szeged, Department of Oncotherapy, Szeged, Hungary. Electronic address: dr.aniko.maraz@gmail.com.
Publikováno v: Urologic oncology [Urol Oncol] 2019 Apr; Vol. 37 (4), pp. 289.e1-289.e9. Date of Electronic Publication: 2019 Jan 21.
Zobrazit plný text záznamu
8
Akademický článek
Outcome of Restarted Sunitinib Treatment in Patients with Metastatic Renal Cell Carcinoma: a Retrospective Trial and Combined Case Reports from Literature.
Autor: Nagyiványi K; National Institute of Oncology, Ráth Gy. u. 7-9, Budapest, 1122, Hungary., Budai B; National Institute of Oncology, Ráth Gy. u. 7-9, Budapest, 1122, Hungary. budai@oncol.hu., Küronya Z; National Institute of Oncology, Ráth Gy. u. 7-9, Budapest, 1122, Hungary., Gyergyay F; National Institute of Oncology, Ráth Gy. u. 7-9, Budapest, 1122, Hungary., Bíró K; National Institute of Oncology, Ráth Gy. u. 7-9, Budapest, 1122, Hungary., Bodrogi I; National Institute of Oncology, Ráth Gy. u. 7-9, Budapest, 1122, Hungary., Géczi L; National Institute of Oncology, Ráth Gy. u. 7-9, Budapest, 1122, Hungary.
Publikováno v: Pathology oncology research : POR [Pathol Oncol Res] 2019 Jan; Vol. 25 (1), pp. 241-247. Date of Electronic Publication: 2017 Oct 30.
Zobrazit plný text záznamu
10
Protection by WR-2721 of the toxicity induced by the combination of cisplatin and 5-fluorouraci
Autor: Peters, G.J., van der Wilt, C.L., Gyergyay, F., van Laar, J.A.M., Treskes, M., van der Vijgh, W.J.F., Pinedo, H.M.
Publikováno v: Peters, G J, van der Wilt, C L, Gyergyay, F, van Laar, J A M, Treskes, M, van der Vijgh, W J F & Pinedo, H M 1992, ' Protection by WR-2721 of the toxicity induced by the combination of cisplatin and 5-fluorouraci ', International Journal of Radiation Oncology Biology Physics, vol. 22, pp. 785-789 .
International Journal of Radiation Oncology Biology Physics, 22, 785-789. Elsevier Inc.
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::b52e0d7d1ff8ecb031b26beab035005a
https://research.vumc.nl/en/publications/c6a2cc11-c089-4d37-b41d-ce989c909828
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje